9-Minute Withdrawal Time Cuts Adenoma Miss Rate in Colonoscopy

TUESDAY, May 23, 2023 (HealthDay News) -- A 9-minute mean withdrawal time (m-WT) for screening colonoscopy significantly reduces the adenoma miss rate (AMR) and advanced adenoma miss rate (AAMR), in addition to increasing adenoma detection rate (ADR), according to a study published in the May issue of the American Journal of Gastroenterology.
Shengbing Zhao, M.D., from the National Quality Control Center of Digestive Endoscopy in Shanghai, and colleagues conducted a multicenter trial in 11 centers involving 733 asymptomatic participants who were randomly assigned to receive segmental tandem screening colonoscopy with a 9-minute withdrawal followed by a 6-minute withdrawal or vice versa (9-minute-first group [9MF], 366 participants; 6-minute-first group [6MF], 367 participants). Lesion-level AMR was the primary outcome.
The researchers found that the 9MF significantly reduced the lesion-level and participant-level AMR (14.5 versus 36.6 percent and 10.9 versus 25.9 percent, respectively), AAMR (5.3 versus 46.9 percent), multiple adenoma miss rate (20.7 versus 56.5 percent), and high-risk adenoma miss rate (14.6 versus 39.5 percent) of 6MF in the intention-to-treat analysis, without reducing the efficiency of detection. A lower false-negative rate was seen for adenomas and high-risk adenomas as well as a lower rate of shortening surveillance schedule in 9MF, accompanied by improved ADR in the 9- versus 6-minute m-WT (42.3 versus 33.5 percent). Even after adjusting for ADR, the independent inverse association between m-WT and AMR remained significant; 9-minute m-WT was an independent predictor for AMR and AAMR.
"Along with the evidence from current trial and previous findings, we suggest that in addition to ADR, the 9-minute WT deserves to be considered as a potential quality indicator to further optimize colonoscopy quality," the authors write.
Related Posts
Los CDC reducen el estimado de la prevalencia de la ómicron en EE. UU.
MIÉRCOLES, 29 de diciembre de 2021 (HealthDay News) -- Los Centros para el...
Company Hid Problems With COVID-19 Vaccines From FDA
TUESDAY, May 10, 2022 (HealthDay News) -- Evidence of quality control problems...
La deambulación en invierno es un peligro real para las personas con Alzheimer
VIERNES, 27 de enero de 2023 (HealthDay News) -- El tiempo invernal puede añadir...